Navigation Links
Sanofi-aventis Announces Good First-quarter 2009 Performance
Date:4/29/2009

HENA study was published in the New England Journal of Medicine in February 2009.
  • Based on the findings of the ACTIVE-A study presented at the American College of Cardiology Scientific Sessions in March, we are planning to file an application to extend the indication of Plavix(R) to atrial fibrillation in the third quarter of 2009.
  • Three new candidates have entered clinical development:

  •             -- BSI-201, a PARP inhibitor, has entered our portfolio following
                   the acquisition of BiPar Sciences. This product could be a
                   potential first-in-class PARP inhibitor, and is currently in
                   phase II clinical trials for the treatment of triple-negative
                   metastatic breast cancer, ovarian cancer, and other types of
                   cancer. The results of the triple-negative metastatic breast
                   cancer Phase II trial will be presented at a plenary session of
                   the Congress of the American Society of Clinical Oncology
                   (ASCO).
                -- Two products have entered Phase I: SAR 110894, an H3 receptor
                   antagonist developed for Alzheimer's disease, and an anti-NGF
                   monoclonal antibody developed in collaboration with Regeneron
                   for pain relief.
    

    • Two new applications for marketing approval have been filed with the regulatory authorities: the Plavix(R)/ Aspirin combination in the European Union, and the new influenza vaccine formulation (high dose Fluzone(R)) in the United States.
    • Five new drug applications have been approved:

                -- the Apidra(R) SoloSTAR(R) pen in the United States, and Apidra(R) and
                   Apidra(R)SoloSTAR(R) in Japan;
                -- Lovenox(R) in Japan, for the prevention of venous thromboembolic
                   events after a
    '/>"/>
    SOURCE Sanofi-aventis
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

    Related medicine news :

    1. Sanofi-Aventis and Roche/Chugais Drugs Will Dominate the Indian Colorectal Cancer Drug Market Through 2013
    2. Sanofi-aventis Affirms Its Commitment to Partnering with Local Communities to Improve Hispanic and African American Health
    3. Apidra(R) SoloSTAR(R), the Easy-to-Use Insulin Delivery Device from sanofi-aventis, Now Available in the United States
    4. Paul Chew Appointed to sanofi-aventis U.S. Chief Science Officer/Chief Medical Officer
    5. Sanofi-aventis Partners with the Hispanic Community in Miami to Increase Health Awareness, Access to Resources and Help Improve Patient Care
    6. Sanofi-aventis Partners with the Hispanic Community in San Antonio to Increase Health Awareness, Access to Resources and Help Improve Patient Care
    7. Sanofi-aventis Delivers 2008 Results Above Guidance
    8. Sanofi-aventis Partners with the Hispanic Community in Bronx to Increase Health Awareness, Access to Resources and Help Improve Patient Care
    9. Sanofi-aventis Partners with the African American Community in Memphis to Increase Health Awareness, Access to Resources and Help Improve Patient Care
    10. Sanofi-aventis U.S. Announces Increased Access to Drugs for Low Income Patients Through Expanded PAP Programs
    11. Sanofi-aventis Partners with the African American Community in Baltimore to Increase Health Awareness, Access to Resources and Help Improve Patient Care
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/30/2014)... (PRWEB) September 30, 2014 TrailMyx.com ... its October Flavor of the Month: raw pumpkin seeds. ... seed of squash”)—are rich in protein, and valued by ... and multiple types of vitamin E. They are prized ... function and proper bowel function. , Of course, pumpkin ...
    (Date:9/30/2014)... Pivotal 5, LLC, a proven leader in ... – The Healthy Way of Life CompanySM (NYSE: LTM) ... Training . KettleWorX Group Training is a three-dimensional training ... of all fitness levels a means to enter into ... rollout to Life Time Athletic destinations will be KettleWorX’s ...
    (Date:9/30/2014)... University of Michigan have described a new approach to ... the time needed for more traditional methods. , ... that is undergoing further investigation as a potential treatment ... , In research published online in the Proceedings ... the lab of Stephen Weiss at the U-M Life ...
    (Date:9/30/2014)... 30, 2014 Visiting Nurse Association (VNA) ... pleased to announce that Steven Landers, MD, MPH, president ... “40 Under 40” award on Monday evening. The ... young businessmen and women who have been making headlines ... business growth, professional excellence and to the community. , ...
    (Date:9/30/2014)... September 30, 2014 During this ... natural approaches to health including achieving hormonal balance, ... deficiencies and detoxification. , The ... , Date: October 6-9, 2014, Location: Online Event, ... http://www2.hotzehwc.com/naturalhealthsummitregistration , Monday, October 6th, Steven ...
    Breaking Medicine News(10 mins):Health News:TrailMyx.com Features October Flavor of the Month 2Health News:Pivotal 5 Announces Life Time Fitness As National Destination For KettleWorX Kettlebell Training 2Health News:Pivotal 5 Announces Life Time Fitness As National Destination For KettleWorX Kettlebell Training 3Health News:New discovery approach accelerates identification of potential cancer treatments 2Health News:Visiting Nurse Association Health Group’s Dr. Steven Landers Honored with NJ BIZ “40 Under 40” Award 2Health News:Visiting Nurse Association Health Group’s Dr. Steven Landers Honored with NJ BIZ “40 Under 40” Award 3Health News:Hotze Health & Wellness Center Announces First Natural Health Summit 2
    ... , CHERRY HILL, N.J., Aug. 25 Nuvilex, ... a shareholder newsletter on September 1, 2009. Additionally, regional shareholder meetings ... on September 17th, and Los Angeles on September 18th. Regional shareholder ... 7, 2009. , , "We are very aware ...
    ... , DES MOINES, Iowa, Aug. 25 The Graham ... Medical Plaza II, a three-story, 70,000 square-foot medical office building serving ... building located on the campus of Carondelet St. Mary,s Hospital, a ... The offices currently include the Carondelet Medical Group, a large family ...
    ... WILMINGTON, Del., Aug. 25 While many pharmaceutical ... and Mitigation Strategy (REMS) programs for many new and old ... program evaluations beginning just 1-1/2 years after each REMS is ... has been issued by risk management expert Jeffrey Fetterman, CEO ...
    ... Nottingham and Health Protection Agency East Midlands are carrying out ... as part of the government,s response to the pandemic. ... contagious for and advise on a ,safe distance, from the ... Nguyen Van Tam of the University of Nottingham,s School of ...
    ... TIPP CITY, Ohio, Aug. 25 One month ago, ... began his quest to bicycle through all 48 states in the continental U.S. ... hometown of Tipp City, Ohio, Nagle now has passed well beyond the halfway ... , , In addition to eyeing a Guinness World ...
    ... WASHINGTON, Aug. ... the United States $4.5 million to resolve allegations that it violated the ... , This ... financial relationships with five physicians that violated the Stark Law. The ...
    Cached Medicine News:Health News:Nuvilex to Issue Positive Shareholder Newsletter 2Health News:Nuvilex to Issue Positive Shareholder Newsletter 3Health News:Nuvilex to Issue Positive Shareholder Newsletter 4Health News:Nuvilex to Issue Positive Shareholder Newsletter 5Health News:Nottingham scientists commissioned for urgent swine flu research 2Health News:College Student's '48 States in 48 Days' Bike Ride Moves Well Beyond the Halfway Point 2Health News:Covenant Medical Center to Pay U.S. $4.5 Million to Resolve False Claims Act Allegations 2
    (Date:9/29/2014)... -- Repeated exposure to broad-spectrum antibiotics in the first two ... say researchers from The Children,s Hospital of ... data from electronic health records from the extensive CHOP ... children with four or more exposures to broad spectrum ... at risk for obesity. The study, published online September ...
    (Date:9/29/2014)... Pharmacists have an important role in ... good clinical trials practices. The Hematology/Oncology Pharmacy Association ... Practice Standards, the first of its kind that ... pharmacists and institutions that conduct clinical trials. The ... the critical role of the pharmacist in the ...
    (Date:9/29/2014)... NEW YORK , Sept. 29, 2014 ... Summary GlobalData,s new report, "EU5 ... market data on the EU5 Capsule Endoscopy Systems market. ... volume (in units) and average prices (in US dollars) ... Recorders and Capsule Endoscopy Workstations. The report ...
    Breaking Medicine Technology:Antibiotic Use by Age 2 Associated with Obesity Risk 2Antibiotic Use by Age 2 Associated with Obesity Risk 3HOPA Introduces First Investigational Drug Service Best Practice Standards For Institutions And Infusion Clinics 2HOPA Introduces First Investigational Drug Service Best Practice Standards For Institutions And Infusion Clinics 3EU5 Capsule Endoscopy Systems Market Outlook to 2020 2EU5 Capsule Endoscopy Systems Market Outlook to 2020 3
    ... and Company (NYSE: LLY ) announced the ... Committee voted today to recommend non-approval of liprotamase, a ... review for the treatment of exocrine pancreatic insufficiency (EPI). ... questions about the degree of efficacy of liprotamase and ...
    ... gloStream, maker of gloEMR and gloPM – the only ... software with Microsoft Office built right in – today announced ... the gloEMR product line. Like its predecessor versions, gloEMR 6.0 ... platform, SQL Server and Microsoft Office so users have access ...
    Cached Medicine Technology:Statement From Lilly on FDA Advisory Committee Recommendation Regarding Liprotamase New Drug Application for Treatment of Exocrine Pancreatic Insufficiency 2gloStream Announces Release of Microsoft-Based, Meaningful Use Certified gloEMR 6.0 2gloStream Announces Release of Microsoft-Based, Meaningful Use Certified gloEMR 6.0 3
    ... EZLink was designed to provide optimal ... associated with a larger network system. Most ... - up to three workstations located in ... features and performance. For creating a paperless ...
    A comprehensive and cost effective LIS solution for the Physicians Office Laboratory....
    LabPak II is a comprehensive multi-user Laboratory Information System designed to meet the requirements of the larger POL, small hospital or private laboratory. It is the next step up from the LabPak...
    ... BMP™ Total Hip Pouch Drape is designed as an ... to dislocate the lower extremity into a sterile pouch ... clear poly and is a generous 60 inches long ... the extremity with a 4 inch wide adhesive strip ...
    Medicine Products: